After 16 years of failing to get one drug permanently licensed...

After 16 years of failing to get one drug permanently licensed out and registered it's hardly any wonder.
Was it 2014 or 2015 they said it would take 12 months to relicense out 1103 and they were exchanging emails on 1102 with potential interested parties.
That all amounted to nix and their word means nothing imo. Just the same as the touted revenues from the Early access program that disappeared with great mystery.
And people blame the negative posts for holding the stock back . Wow that's rich.
...this company has burnt so many investors in the past by not delivering it's hardly any wonder that there is no market confidence.
Meanwhile they plan on flogging off 20% of the company at all time historical lows ...for an amount that barely covers the cost of Diamond for another 2 years.
And this is meant to be a positive Ann ??I mean seriously you guys ...are you all that blind??
...as for the international board comment well they haven't attracted much since their appointment (coming up to 2 years?)but we did see a spectacular slide in the sp.
Really the amazing thing is that this all centres around some first generation antisense compounds that are becoming increasingly obsolete imo
The new generation of antisense drugs are more potent and supposedly less toxic so it's hardly any wonder they have not been able to find anyone on this planet to take them up.
Seriously it's been 7 years ? Since Teva handed back 1102 for something to do with a failed monkey study and now everyone gets excited that they dug up some old data. If any of the data was that good then it sure as hell wouldn't take the better part of a decade to license out 1102 again....but here we are with patent life running out and new drugs superseding.
That is the reality and there are all the above reasons and more for why and where this capital sucking company is where it is.